InsiderTrades

Form 4 for MET MetLife

Accepted 2022-02-24 00:00:00 ET · period of report 2022-02-22 · accession 0001099219-22-000028 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DM 2022-02-24 2022-02-22 MET PODLOGAR SUSAN M EVP, Chief HR Off A - Grant — +30.2K 62.7K +93% —
D 2022-02-24 2022-02-22 MET PODLOGAR SUSAN M EVP, Chief HR Off F - Tax $68.96 -11.4K 51.2K -18% -$788.8K
D 2022-02-24 2022-02-22 MET PODLOGAR SUSAN M EVP, Chief HR Off A - Grant $0.00 +10.8K 10.8K New $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2022-02-22 A A 3,590 — 36,105 D — — (F1) Restricted stock unit award under the MetLife, Inc. 2015 Stock and Incentive Compensation Plan.
2 Common Common Stock 2022-02-22 A A 26,582 — 62,687 D — — (F2) Shares acquired from the determination of the performance factor for and payout of 2019-2021 performance share award under the MetLife, Inc. 2015 Stock and Incentive Compensation Plan.
3 Common Common Stock 2022-02-22 F D 11,438 $68.96 51,249 D — —
4 Derivative Employee Stock Options (right to buy) 2022-02-22 A A 10,766 $0.00 10,766 D $68.96 · — to 2032-02-21 10,766 Common Stock (F4) The options become exercisable in substantially equal installments on each of the first three anniversaries of the grant date.